Shares of Amgen Inc. (NASDAQ: AMGN) are seeing a small gain in after-hours trading. The troubled biotech giant announced that findings from its head-to-head, double-blind trial comparing the effects of denosumab in…
Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its corporate structure, increasing focus on emerging markets such as China, Russia, Brazil,…
Big Pharma continues to throw ballast out of the balloon in the hopes of staying aloft. The latest victim of declining fortunes in the industry is Merck (MRK), which seems to have…
Douglas A. McIntyre According to Reuters, UBS (UBS) will cut 5,500 jobs. The company is also selling $15 billion in subprime mortgage paper to Blackrock. Reuters writes that Bernanke says that high foreclosure rates are…
There are lots of names moving in biotech and related fields today, and below are some of the top movers: Anika Therapeutics Inc. (NASDAQ: ANIK) moving up after reporting solid first quarter…
According to Reuters, Cadbury is looking at buying Hershey. Reuters writes that banks being sued by Clear Channel (CCU) have asked for a delay of a Texas trial. Reuters reports that share…
Merck (MRK) had high hopes for its cholesterol drug Cordaptive According to The Wall Street Journal, things did not work out. The paper reports that the agency issuing a "not approvable" letter…
Douglas A. McIntyre According to Reuters, US senator Charles Schumer has asked the SEC to look at conflicts of interest at bond rating firms. Reuters writes that Washington Mutual (WM) are in favor of the…
According to Reuters, US car sales for March are likely to be off sharply. Reuters writes that Microsoft (MSFT) will not raise its bid for Yahoo! (YHOO) Reuters reports that UBS (UBS)…
The largest losers among the big companies in the S&P 500 for the first quarter were: Microsoft (MSFT) down 21.6%, Google (GOOG) down 36.7%, Apple (AAPL) down 27.8%, Intel (INTC) down 22%,…
Schering-Plough (SGP) Bad news on key cholesterol drug marketed with Merck. Shares fall to $14 from 52-week high of $33.81. Merck (MRK) Pulled down for the same reason. Sells off to $36.82…
Usually drug companies look forward to presenting data on their drugs and medical treatments. The the American College of Cardiology meeting was this weekend, and the findings and recommendations are worse than…
Douglas A. McIntyre According to Reuters, the Treasury Department will announce a proposed major overhaul of the US financial regulatory system. Reuters writes that Yahoo! (YHOO) introduced Shine, a site for women. Reuters writes that…
Investors usually try to find stocks where they run for cover when the stock market is in turmoil. This Monday is no exception after seeing the Bear Stearns implosion "takeunder" and the…
Those rummaging through the garbage of 52-week low lists are usually bottom-fishing investors or desperate CEOs. But, the list is so broad that it has become a tableau of the market as…
